Related Experiment Videos
Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy
J Marin-Garcia1, R Ananthakrishnan, M J Goldenthal
1Molecular Cardiology Institute, Highland Park, New Jersey 08904, USA.
Insights
Severe hypertrophic cardiomyopathy (HCM) is linked to defects in mitochondrial respiratory enzymes. This study found specific enzyme activity defects and mtDNA depletion in HCM patients, suggesting a role in disease development.
Area of Science:
- Cardiology
- Mitochondrial Biology
- Genetics
Background:
- Mitochondrial dysfunction, including abnormalities in mitochondrial DNA (mtDNA) and respiratory enzymes, is implicated in cardiomyopathy.
- Hypertrophic cardiomyopathy (HCM) is a significant cardiac condition with complex underlying mechanisms.
Observation:
- This study investigated four patients with severe HCM, analyzing cardiac mitochondrial enzyme activity and mtDNA.
- Specific defects were identified in mitochondrial respiratory chain complexes I, III, IV, and V in these patients.
- One patient exhibited marked depletion of mtDNA, a finding not previously reported in HCM.
Findings:
- The study found frequent specific defects in cardiac mitochondrial respiratory enzyme activity in severe HCM cases.
- Commonly associated mtDNA point mutations and deletions were absent in the studied HCM patients.
- A significant finding was the presence of cardiac mtDNA depletion in one patient, suggesting its potential involvement.
Implications:
- These findings highlight the frequent occurrence of specific mitochondrial respiratory enzyme defects in HCM.
- Cardiac mtDNA depletion warrants further investigation for its potential role in the pathogenesis of HCM.
- Understanding these mitochondrial abnormalities could lead to new diagnostic markers or therapeutic targets for HCM.
Abstract:
Abnormalities in specific mitochondrial respiratory enzymes and DNA (mtDNA) have been reported in cardiomyopathy. In this study, we report 4 cases of severe hypertrophic cardiomyopathy (HCM) in which specific cardiac mitochondrial enzyme activity defects were found, including complex I (n = 2), complex III (n = 2), complex IV (n = 2) and complex V (n = 1). Other abnormalities were also noted including a marked depletion of mtDNA (n = 1) and decreased content of subunit 2 of cytochrome c oxidase (n = 1). None of the mtDNA point mutations and common deletions previously found in association with cardiomyopathy were detected in these patients. These data indicate that specific respiratory enzyme activity defects are frequently present in HCM. Also, our finding of a marked depletion of mtDNA in 1 patient suggests that cardiac mtDNA depletion, previously unreported in HCM, needs further examination in order to establish whether it plays a primary role in its pathogenesis.